Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder

  • Author: Frederick L. Altice, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 2/5/20 (What's New)

Summary

    Medically Supervised Opioid Withdrawal
    • Gradual taper using methadone or buprenorphine is the best-supported method for withdrawing from opioids[SAMHSA 2015; ASAM 2015]
    • Supervised opioid withdrawal without chronic opioid substitution therapy should be reserved for people with short-term opioid use (less than 2 years), young adults, and noninjectors[Mattick 2003a; Amato 2004]
    Pharmacotherapy for Opioid Dependence
    • Most effective chronic treatment for opioid addiction for patients with long-term opioid-dependence, particularly PWIDs, is opioid substitution therapy,[Amato 2008; Mattick 2009] although data also supports use of extended-release naltrexone[Krupitsky 2011; Baser 2011]
      • Methadone
        Buprenorphine
          Naltrexone
            Clonidine

          Action required

          Keywords: Initial Antiretroviral Therapy, IV Drug Use, Special Populations, Treatment Complications

          ©2020 Clinical Care Options, LLC. All Rights Reserved.

          The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.